Australia markets open in 7 hours 34 minutes

ProQR Therapeutics N.V. (PRQR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.9700-0.0400 (-1.99%)
As of 12:26PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 163.52M
Enterprise value 57.36M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)23.46
Price/book (mrq)3.71
Enterprise value/revenue 8.81
Enterprise value/EBITDA -2.38

Trading information

Stock price history

Beta (5Y monthly) 0.25
52-week change 3-7.80%
S&P500 52-week change 322.64%
52-week high 33.2900
52-week low 31.1100
50-day moving average 32.1324
200-day moving average 31.7789

Share statistics

Avg vol (3-month) 3206.82k
Avg vol (10-day) 3155.58k
Shares outstanding 581.35M
Implied shares outstanding 681.35M
Float 857.49M
% held by insiders 118.87%
% held by institutions 140.33%
Shares short (15 Apr 2024) 4241.52k
Short ratio (15 Apr 2024) 41.4
Short % of float (15 Apr 2024) 40.42%
Short % of shares outstanding (15 Apr 2024) 40.30%
Shares short (prior month 15 Mar 2024) 4272.13k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-280.12%

Management effectiveness

Return on assets (ttm)-14.06%
Return on equity (ttm)-51.33%

Income statement

Revenue (ttm)6.59M
Revenue per share (ttm)0.08
Quarterly revenue growth (yoy)171.20%
Gross profit (ttm)N/A
EBITDA -34.11M
Net income avi to common (ttm)-28.12M
Diluted EPS (ttm)-0.3700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)118.92M
Total cash per share (mrq)1.46
Total debt (mrq)19.73M
Total debt/equity (mrq)47.68%
Current ratio (mrq)3.54
Book value per share (mrq)0.51

Cash flow statement

Operating cash flow (ttm)21.55M
Levered free cash flow (ttm)62.8M